All long Covid articles
-
NewsWho is more likely to get long COVID?
Scientists have identified the key genetic drivers behind long COVID, revealing why some people continue to experience debilitating symptoms long after their initial infection.
-
NewsCould hidden infections be fueling long COVID?
For millions suffering from long COVID, their persistent breathlessness, brain fog and fatigue remain a maddening mystery, but microbiologists think they may have cracked the case. The review argues that co-infections acquired before or during COVID could cause symptoms to persist indefinitely for many people.
-
NewsTo treat long COVID, we must learn from historical chronic illnesses, medical researchers say
Scientists and doctors have highlighted the importance of studying long COVID in the context of other post-acute infection syndromes or chronic illnesses. By analyzing historical accounts of other epidemics, researchers can gain important perspective on the effects of these chronic illnesses.
-
NewsWomen are three times more likely than men to get severe long COVID: Here’s why
Researchers have identified a distinct immune signature in female long Covid patients versus male patients. They found evidence of ’gut leakiness’ in the women patients, including elevated blood levels of intestinal fatty acid binding protein, lipopolysaccharide, and the soluble protein CD14 — all signs of gut inflammation that can then trigger further systemic inflammation.
-
NewsCOVID-19 vaccination lowers long COVID risk in adolescents
Adolescents who were vaccinated against COVID-19 were less likely to develop long COVID after their first SARS-CoV-2 infection than unvaccinated peers, finds a new study.
-
NewsLow-dose cannabis compound reduces side effects of HIV treatment
Long-term, low doses of THC mitigate many harmful side effects and inflammation caused by HIV and antiretroviral therapy (ART). Benefits included increased production of serotonin, while inflammation, cholesterol and harmful secondary bile acids were all reduced.
-
NewsBrain imaging technique helps uncover the molecular basis of long COVID brain fog
A research team has made a significant breakthrough in understanding the cause of Long COVID brain fog. They hypothesized that patients with brain fog might exhibit disrupted expression of AMPA receptors (AMPARs)based on prior research into psychiatric and neurological disorders.
-
NewsRisk of long COVID in kids doubles after second infection
Children and adolescents were twice as likely to experience long COVID after catching COVID for the second time, compared to their peers with a single previous infection, results running counter to the popular perceptions that COVID in children is ‘mild’.
-
NewsBeyond viruses: Expanding the fight against infectious diseases
The newly renamed Gladstone Infectious Disease Institute has broadened its mission to address global health threats ranging from antibiotic resistance to infections that cause chronic diseases.
-
NewsMajor report tackles Covid’s cardiovascular crisis head-on
Regular Covid vaccinations should continue worldwide to reduce cardiac risks associated with the virus - according to new research.
-
NewsGlobal analysis reveals overlooked hotspots at risk for long COVID due to early disability burdens
An international team of researchers has conducted the most comprehensive global-to-local analysis to date on long COVID risk, using disability data from the height of the pandemic to identify vulnerable populations.
-
NewsMount Sinai creates first manual for treating infection-associated chronic illness for clinicians
Mount Sinai has launched the country’s first clinical manual for treating infection-associated chronic illnesses (IACIs). This comprehensive guide, prepared by the Cohen Center for Recovery From Complex Chronic Illnesses, part of the Department of Rehabilitation and Human Performance, will help clinicians better diagnose and care for patients with conditions such ...
-
NewsStudy: Long COVID remains a substantial financial and medical burden
Individuals with long COVID-19 experienced worse financial and employment outcomes – lasting up to three years after their initial infection. Notably, vaccination against COVID-19 was associated with strikingly improved work and financial outcomes.
-
NewsWhat exactly is Long COVID? It depends who you ask
New research finds that the definition of Long COVID varies so widely across published studies that the percentage of people identified as having the condition can differ dramatically, making it harder to treat patients and advance research.
-
NewsResearchers identify a potential biomarker for long COVID
Researchers have identified a potential biomarker for long COVID. The study results detail the detection of SARS-CoV-2 protein fragments within extracellular vesicles (EVs) — tiny, naturally occurring packages that help cells share proteins, metabolites, and other materials.
-
NewsQ&A: Why do symptoms linger in some people after an infection?
A new review highlights that long COVID and ME/CFS share many of the same biological problems such as inflammation in the brain, issues with how cells produce energy, and problems with the immune system.
-
NewsEconomically disadvantaged patients at greater risk for long COVID
A study found that people with social risk factors including economic instability and food insecurity at the time of COVID-19 infection were at greater risk for long COVID.
-
NewsGut microbiome may predict “invisible” chronic fatigue syndrome and long COVID
Millions suffering from myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may be closer to personalized care, according to new research that shows how the disease disrupts interactions between the microbiome, immune system, and metabolism.
-
NewsPeople with COVID-like symptoms took up to nine months post-infection to regain mental well-being
New research finds that people with COVID-like symptoms returned to optimal physical well-being an average of three months after infection, but took up to nine months to return to top mental well-being.
-
NewsDisrupting the residual triggers of COVID-19 in patients with long COVID
Spatial transcriptomics reveals activation of SARS-CoV-2-related signaling pathways in the epipharynx of patients with long COVID.